Please use this identifier to cite or link to this item:
https://doi.org/https://doi.org/10.1186/s13019-024-02925-2
Title: | Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients? | Authors: | Faizus Sazzad Hai Dong Luo Guohao Chang Duoduo Wu Zhi Xian Ong Theo Kofidis Giap Swee Kang |
Keywords: | Coronary artery bypass grafting Intra-aortic balloon pump Propensity score matching In-hospital complications Open heart surgery |
Issue Date: | 24-Jun-2024 | Citation: | Faizus Sazzad, Hai Dong Luo, Guohao Chang, Duoduo Wu, Zhi Xian Ong, Theo Kofidis, Giap Swee Kang (2024-06-24). Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?. Journal of Cardiothoracic Surgery 19. ScholarBank@NUS Repository. https://doi.org/https://doi.org/10.1186/s13019-024-02925-2 | Rights: | CC0 1.0 Universal | Abstract: | Background The aim of this study was to determine whether pre-operative intra-aortic balloon pump (IABP) insertion improves surgical outcomes in high-risk coronary artery bypass grafting (CABG) patients. Methods Patients with a EuroSCORE II greater than 1.2% who underwent CABG from 2009 to 2016 were included in the study, while those who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing preoperative IABP insertion (EuroSCORE II>5.018%) and 1198 patients in the non-IABP group before matching; after propensity score matching (PSM), both groups consisted of a matched cohort of 250 patients. Results 30-day mortality events occurred in 9 (3.6%) non-IABP group and in 12 (4.8%) IABP patients (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p=0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value=0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value=0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value=0.011). Conclusion Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders. | Source Title: | Journal of Cardiothoracic Surgery | URI: | https://scholarbank.nus.edu.sg/handle/10635/249230 | ISSN: | 1749-8090 | DOI: | https://doi.org/10.1186/s13019-024-02925-2 | Rights: | CC0 1.0 Universal |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
49. s13019-024-02925-2.pdf | Published version (Open access) | 3.47 MB | Adobe PDF | OPEN | Published | View/Download |
This item is licensed under a Creative Commons License